Checked.be
Active
BE 0690.628.419Private limited company (pre-2019)
Dr. Stuart Wills pneumoloog
Kleemstraat 15 ·9111 Sint-Niklaas, Belgium· 8 yrs active
Conclusion
The computed 12-month bankruptcy probability of Dr. Stuart Wills pneumoloog is 2.7% (moderate). The 2023 annual accounts show equity of €8k and a net result of €-24k. Equity is shrinking by ~8% per year across the filed fiscal years. The company has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 6 annual accounts.
Key figures
| Equity | €8k |
| Net result | €-24k |
| Active | 8 yrs |
| Locations | 1 |
Financial profile
32
/ 100
Fragile profile, watch profitability in particular.
All 5 axes are computed from data Checked has read.
Health
7
Profitability
0
Solvency
23
Growth
32
Stability
100
Bankruptcy probability (12 mo)
Risk Assessment
0 / 100
Low riskTrust signals
More than 3 years active
Founded in 2018, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Checked score
7
/ 100
Critical
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.
Indicative credit limit
No credit
negative equity or figures too weak
Score history
85
2018
78
2019
93
2020
62
2021
63
2022
7
2023
purely financial, excl. current insolvency signals
Score components
Liquidity
Current ratio 0.99 (< 1.0)
-10
Leverage
Debt/equity 4.75 (> 3.0)
-10
Profitability
Negatieve ROE -282%
-10
Interest coverage
Interest coverage -104.7× (< 1.5×)
-10
Profit trend
Net profit down YoY
-3
Computed by Checked from the NBB filing for FY 2023. Indicative, not credit advice.
Financial overview
Annual accounts filed on 07-10-2024 with the NBB · fiscal year 2023 · micro schema
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
declining
Equity: declining trend of ~8%/year over 6 fiscal years, indicative, assuming unchanged policy.
Solid line = filed figures · dashed = extended trend · area = indicative range.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
€-16k
-
18-23
€-24k
-62.3%
18-23
€-22k
-1521.4%
18-23
€49k
-25.2%
18-23
€8k
-73.8%
18-23
€-434
-
18-23
€6k
-36.6%
18-23
€40k
+22.7%
18-23
€36k
+26.5%
18-23
€5k
0.0%
18-23
0.99
-48.3%
18-23
0.99
-48.3%
18-23
17.4%
-65.0%
18-23
4.75
+369.0%
18-23
-282.2%
-520.1%
18-23
-49.0%
-117.0%
18-23
-104.74
-
18-23
Figures by fiscal year and ratios
| Fiscal year | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - | - |
| EBITDA | €-16k | €10k | - | €16k | €7k |
| Net profit | €-24k | €-15k | €-699 | €6k | €3k |
| Cash flow | €-22k | €-1k | - | €12k | €10k |
| Staff costs | - | - | - | - | - |
| Income taxes | €6k | €9k | €3k | €3k | €2k |
| Dividends | - | - | - | - | - |
| Total assets | €49k | €65k | €90k | €78k | €93k |
| Equity | €8k | €32k | €47k | €48k | €42k |
| Debt | €40k | €33k | €43k | €30k | €50k |
| of which ≤ 1y | €36k | €28k | €38k | €26k | €46k |
| of which > 1y | €5k | €5k | €5k | €5k | €5k |
| Working capital | €-434 | €26k | €31k | €35k | €27k |
| Employees (FTE) | - | - | - | - | - |
Ratios (computed)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Current ratio | 0.99 | 1.91 | 1.82 | 2.37 | 1.60 |
| Quick ratio | 0.99 | 1.91 | 1.82 | 2.37 | 1.60 |
| Working capital ratio | -0.9% | 39.3% | 34.8% | 45.3% | 29.6% |
| Solvency | 17.4% | 49.7% | 52.5% | 61.1% | 45.5% |
| Debt / equity | 4.75 | 1.01 | 0.91 | 0.10 | 0.11 |
| Long-term debt ratio | 0.55 | 0.14 | 0.10 | 0.10 | 0.11 |
| Interest coverage | -104.74 | 4.15 | - | - | - |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| ROA | -49.0% | -22.6% | -0.8% | 7.1% | 2.8% |
| ROE | -282.2% | -45.5% | -1.5% | 11.7% | 6.2% |
| EBITDA margin | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - |
| Days inventory (DSI) | - | - | - | - | - |
Balance-sheet composition 2023
Full annual accounts (24 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
| Line item | Code | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Balance sheet, Assets | ||||||
| TOTAL ASSETS | 20/58 | €49k | €65k | €90k | €78k | €93k |
| Fixed assets | 21/28 | €14k | €11k | €20k | €17k | €19k |
| Tangible fixed assets | 22/27 | €6k | €4k | €13k | €13k | €19k |
| Financial fixed assets | 28 | €7k | €7k | €7k | €4k | - |
| Current assets | 29/58 | €35k | €54k | €69k | €61k | €73k |
| Amounts receivable within one year | 40/41 | €29k | €45k | €61k | €27k | €67k |
| Cash & bank | 54/58 | - | €2k | €1k | €28k | - |
| Balance sheet, Equity & liabilities | ||||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €49k | €65k | €90k | €78k | €93k |
| Equity | 10/15 | €8k | €32k | €47k | €48k | €42k |
| Contributions / capital | 10/11 | €13k | €13k | €13k | - | €13k |
| Reserves | 13 | €30k | €30k | €30k | €30k | €30k |
| Accumulated profits (losses) | 14 | €-34k | €-10k | €5k | €6k | - |
| Amounts payable | 17/49 | €40k | €33k | €43k | €30k | €50k |
| Amounts payable after one year | 17 | €5k | €5k | €5k | €5k | €5k |
| Amounts payable within one year | 42/48 | €36k | €28k | €38k | €26k | €46k |
| Trade debts payable within one year | 44 | €10k | €17k | €14k | €1k | €10k |
| Income statement | ||||||
| Gross operating margin | 9900 | €-15k | €11k | €5k | €18k | €10k |
| Operating result | 9901 | €-18k | €-4k | €2k | €10k | €-206 |
| Financial income | 75 | - | - | - | - | €6k |
| Financial charges | 65 | €157 | €2k | €84 | €697 | €288 |
| Result before taxes | 9903 | €-18k | €-6k | €2k | €9k | €5k |
| Income taxes | 67/77 | €6k | €9k | €3k | €3k | €2k |
| Net result for the period | 9904 | €-24k | €-15k | €-699 | €6k | €3k |
| Result to be appropriated | 9905 | €-24k | €-15k | €-699 | €6k | €3k |
Legal Structure
| NACE primary | - |
| Legal form | Private limited company (pre-2019)(015) |
| Incorporation | 15-02-2018 |
| Status | Active |
| Postal code | 9111 |
Establishment units
Dr. Stuart Wills pneumoloog
since 20182.286.088.179
Real-estate footprint
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11472C0079/00E000 | Flanders | 3.4 ha | 1 · 2.7 ha | - |
| 46002C0507/00W000 | Flanders | 9,723 m² | 1 · 532 m² | 13.2 m · 4 fl. |
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
2024
07-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 68 days late
2023
31-12
Financial
Weakest financial yearnet €-24k
Net result drops to €-24k, the lowest in the series.
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
10-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 344 days late
2022
24-03
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 236 days late
2021
24-06
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 328 days late
24-06
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 694 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Belgian State Gazette reading coverage
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Credit advice
Company registry (CBE)
Names & trade names
| Legal nameNL | Dr. Stuart Wills pneumoloog |